Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Westhive expanding in Greater Zurich Area
Zurich/Zug – Zurich-based coworking space provider Westhive intends to open a new site in the Tech Cluster Zug in summer 2022. Here, it will offer flexible workspace and conference rooms. A coffee bar and gym are also planned.
Agire Foundation creates innovation platform for SMEs
Manno TI – The Agire Foundation has launched a new online platform, Scouting Days Agire. This enables SMEs from the Italian-speaking part of Switzerland to start a “call for innovation” to find inventors, researchers, project partners and investors for their own innovations.
Roambee acquires Modum
Zurich/Santa Clara - Modum, the specialist in last mile-focused cold chain monitoring, has been taken over by Roambee. With this acquisition, the Silicon Valley logistics firm intends to expand its offering to include cold chain transparency.
Sygnum expands decentralized finance token portfolio
Zurich - Sygnum is launching regulated banking services for various kinds of decentralized finance tokens. In this sense, the crypto bank is aiming to build a bridge between digital and conventional financial services.
Researchers keeping track of viral evolution
Zurich – Researchers at the Swiss Federal Institute of Technology in Zurich have been successful in their attempts to mimic a decisive step in the evolution of viruses: the formation of a structure that can store genetic material. This will also be instructive for the development of future vaccines, cell therapies and drug delivery mechanisms.
Therapy discovered to combat COVID-19 and flu
Zurich - Inflamed pharma, a project enterprise of Xlife Sciences, has discovered an active ingredient that is able to reduce viral load by up to 90 percent in coronavirus patients and those suffering from influenza infections. At the same time, it leads to a significant reduction in inflammatory processes. Drugs are now already being produced.
Nexxiot raises 25 million dollars
Zurich – Investors have pledged a total of 25 million US dollars to Nexxiot as part of a financing round. With this fresh capital injection, the global specialist for digital logistics and the Internet of Things is seeking further efficiency gains in the worldwide cargo transport sector. Nexxiot is above all planning to expand in the USA
NEST opens up for online tours
Dübendorf ZH - The modular research and innovation building NEST, operated by Empa and the aquatic research institute Eawag, can now be visited virtually by anyone at any time. This should ensure that news related to the numerous innovations developed and demonstrated by NEST can be spread far more quickly – to an international audience as well.
3Brain wants to expedite drug development
Wädenswil ZH - 3Brain AG has launched a new technology for drug development. It combines microchips with artificial intelligence and aims to help active substance candidates to be investigated in more detail before a clinical trial is conducted.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space